PRKAA1 and ovarian carcinoma: In contrast, it has been reported that activation of AMPK by Lysophosphatidic acid (LPA) induced cell migration through the signaling pathway to cytoskeletal dynamics and increases tumor metastasis in ovarian cancer [39].